Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367-2. Online ahead of print.ABSTRACTBACKGROUND: Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of...
Source: Australian Family Physician - April 6, 2024 Category: Primary Care Authors: GBD 2021 Causes of Death Collaborators Source Type: research
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367-2. Online ahead of print.ABSTRACTBACKGROUND: Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of...
Source: Australian Family Physician - April 6, 2024 Category: Primary Care Authors: GBD 2021 Causes of Death Collaborators Source Type: research
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367-2. Online ahead of print.ABSTRACTBACKGROUND: Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of...
Source: Australian Family Physician - April 6, 2024 Category: Primary Care Authors: GBD 2021 Causes of Death Collaborators Source Type: research
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367-2. Online ahead of print.ABSTRACTBACKGROUND: Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of...
Source: Australian Family Physician - April 6, 2024 Category: Primary Care Authors: GBD 2021 Causes of Death Collaborators Source Type: research
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367-2. Online ahead of print.ABSTRACTBACKGROUND: Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of...
Source: Australian Family Physician - April 6, 2024 Category: Primary Care Authors: GBD 2021 Causes of Death Collaborators Source Type: research
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367-2. Online ahead of print.ABSTRACTBACKGROUND: Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of...
Source: Australian Family Physician - April 6, 2024 Category: Primary Care Authors: GBD 2021 Causes of Death Collaborators Source Type: research
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367-2. Online ahead of print.ABSTRACTBACKGROUND: Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of...
Source: Australian Family Physician - April 6, 2024 Category: Primary Care Authors: GBD 2021 Causes of Death Collaborators Source Type: research
Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines
CONCLUSIONS: Currently, few evidence-based indications support the routine use of albumin in clinical practice to improve patient outcomes. These guidelines provide clinicians with actionable recommendations on the use of albumin.PMID:38447639 | DOI:10.1016/j.chest.2024.02.049 (Source: Australian Family Physician)
Source: Australian Family Physician - March 6, 2024 Category: Primary Care Authors: Jeannie Callum Nikolaos J Skubas Aarti Bathla Homa Keshavarz Edward G Clark Bram Rochwerg Dean Fergusson Sesmu Arbous Seth R Bauer Louise China Mark Fung Rachel Jug Michael Neill Cary Paine Katerina Pavenski Prakesh S Shah Susan Robinson Hua Shan Zbigniew Source Type: research
Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines
CONCLUSIONS: Currently, few evidence-based indications support the routine use of albumin in clinical practice to improve patient outcomes. These guidelines provide clinicians with actionable recommendations on the use of albumin.PMID:38447639 | DOI:10.1016/j.chest.2024.02.049 (Source: Australian Family Physician)
Source: Australian Family Physician - March 6, 2024 Category: Primary Care Authors: Jeannie Callum Nikolaos J Skubas Aarti Bathla Homa Keshavarz Edward G Clark Bram Rochwerg Dean Fergusson Sesmu Arbous Seth R Bauer Louise China Mark Fung Rachel Jug Michael Neill Cary Paine Katerina Pavenski Prakesh S Shah Susan Robinson Hua Shan Zbigniew Source Type: research
Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines
CONCLUSIONS: Currently, few evidence-based indications support the routine use of albumin in clinical practice to improve patient outcomes. These guidelines provide clinicians with actionable recommendations on the use of albumin.PMID:38447639 | DOI:10.1016/j.chest.2024.02.049 (Source: Australian Family Physician)
Source: Australian Family Physician - March 6, 2024 Category: Primary Care Authors: Jeannie Callum Nikolaos J Skubas Aarti Bathla Homa Keshavarz Edward G Clark Bram Rochwerg Dean Fergusson Sesmu Arbous Seth R Bauer Louise China Mark Fung Rachel Jug Michael Neill Cary Paine Katerina Pavenski Prakesh S Shah Susan Robinson Hua Shan Zbigniew Source Type: research
Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines
CONCLUSIONS: Currently, few evidence-based indications support the routine use of albumin in clinical practice to improve patient outcomes. These guidelines provide clinicians with actionable recommendations on the use of albumin.PMID:38447639 | DOI:10.1016/j.chest.2024.02.049 (Source: Australian Family Physician)
Source: Australian Family Physician - March 6, 2024 Category: Primary Care Authors: Jeannie Callum Nikolaos J Skubas Aarti Bathla Homa Keshavarz Edward G Clark Bram Rochwerg Dean Fergusson Sesmu Arbous Seth R Bauer Louise China Mark Fung Rachel Jug Michael Neill Cary Paine Katerina Pavenski Prakesh S Shah Susan Robinson Hua Shan Zbigniew Source Type: research
Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines
CONCLUSIONS: Currently, few evidence-based indications support the routine use of albumin in clinical practice to improve patient outcomes. These guidelines provide clinicians with actionable recommendations on the use of albumin.PMID:38447639 | DOI:10.1016/j.chest.2024.02.049 (Source: Australian Family Physician)
Source: Australian Family Physician - March 6, 2024 Category: Primary Care Authors: Jeannie Callum Nikolaos J Skubas Aarti Bathla Homa Keshavarz Edward G Clark Bram Rochwerg Dean Fergusson Sesmu Arbous Seth R Bauer Louise China Mark Fung Rachel Jug Michael Neill Cary Paine Katerina Pavenski Prakesh S Shah Susan Robinson Hua Shan Zbigniew Source Type: research
Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines
CONCLUSIONS: Currently, few evidence-based indications support the routine use of albumin in clinical practice to improve patient outcomes. These guidelines provide clinicians with actionable recommendations on the use of albumin.PMID:38447639 | DOI:10.1016/j.chest.2024.02.049 (Source: Australian Family Physician)
Source: Australian Family Physician - March 6, 2024 Category: Primary Care Authors: Jeannie Callum Nikolaos J Skubas Aarti Bathla Homa Keshavarz Edward G Clark Bram Rochwerg Dean Fergusson Sesmu Arbous Seth R Bauer Louise China Mark Fung Rachel Jug Michael Neill Cary Paine Katerina Pavenski Prakesh S Shah Susan Robinson Hua Shan Zbigniew Source Type: research
The Association Between Short-Acting β < sub > 2 < /sub > -Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
CONCLUSION: Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.PMID:38310584 | PMC:PMC10879376 | DOI:10.1007/s12325-023-02746-0 (Source: Australian Family Physician)
Source: Australian Family Physician - February 4, 2024 Category: Primary Care Authors: David Price Christine Jenkins Kerry Hancock Rebecca Vella Florian Heraud Porsche Le Cheng Ruth Murray Maarten Beekman Sinthia Bosnic-Anticevich Fabio Botini Victoria Carter Angelina Catanzariti Joe Doan Kirsty Fletton Ata Kichkin Thao Le Chantal Le Lievre Source Type: research
The Association Between Short-Acting β < sub > 2 < /sub > -Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
CONCLUSION: Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.PMID:38310584 | PMC:PMC10879376 | DOI:10.1007/s12325-023-02746-0 (Source: Australian Family Physician)
Source: Australian Family Physician - February 4, 2024 Category: Primary Care Authors: David Price Christine Jenkins Kerry Hancock Rebecca Vella Florian Heraud Porsche Le Cheng Ruth Murray Maarten Beekman Sinthia Bosnic-Anticevich Fabio Botini Victoria Carter Angelina Catanzariti Joe Doan Kirsty Fletton Ata Kichkin Thao Le Chantal Le Lievre Source Type: research
